5:10 PM
 | 
Nov 11, 2009
 |  BC Extra  |  Financial News

Regeneron up after deal expansion

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) gained $3.15 (20%) to $18.95 on Wednesday after expanding a 2007...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >